The Endocrine Society now issued a Clinical Practice Guideline (CPG) advising against the use of testosterone therapy in healthy girls. Although the FDA approved testosterone therapy for the treatment
of disorders affecting the testes, pituitary and hypothalamus, it hasn't been approved for treating age-associated declines in testosterone levels. The U.S. National Institute on Aging is also anticipated to release the results of research on the safety of testosterone. The study involved about 800 elderly men with low testosterone and symptoms related to this illness, for example http://tinyurl.com/hoqq96f
physical and sexual dysfunction. Since the men's heart health was monitored, the research is expected to shed more light on the safety of testosterone treatment.
Research has shown that testosterone deficiency is associated with a number of important health problems such as obesity, diabetes, metabolic syndrome, and bone fractures Men who meet medical standards for treatment should get therapy. Actually, your testosterone levels have probably been slowly falling for some time, a decline that usually starts around age 30.
And many women have a knee-jerk feeling that any hormone treatment can increase their risk of breast cancer. Nevertheless, clinical studies show that testosterone not only does not increase a woman's risk of breast cancer , it may play a vital role in warding off the disease. Glaser thinks this will likely stay the status quo for a little while, given the prohibitive cost of running the long-term safety studies needed to gain FDA approval that is more total.